Clinical trial
Phase 2a Double-Blind Placebo-Controlled Trial of Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
NCT05886582 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2a Double-Blind Placebo-Controlled Trial of Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 11, 2023
- Completion date
- August 11, 2026
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.